Document Detail


Financial disclosures of scientific papers presented at the 2003 RSNA Annual Meeting: association with reporting of non-Food and Drug Administration-approved uses of industry products.
MedLine Citation:
PMID:  16641343     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To retrospectively characterize the extent and nature of financial relationships with industry that are disclosed in the abstracts of scientific papers presented at the 2003 Radiological Society of North America (RSNA) Annual Meeting and to retrospectively assess whether the presence of relationships between researchers and industry was associated with a discussion on the use of products or devices that are not yet approved by the U.S. Food and Drug Administration (FDA). MATERIALS AND METHODS: Printed abstracts of scientific papers published in the 2003 Radiological Society of North America Scientific Assembly and Annual Meeting Program were classified according to the number and type of financial relationships disclosed. Also recorded was whether the abstracts discussed non-FDA-approved use of a product. Abstracts with and those without disclosures were then compared by using the Fisher exact test with respect to the percentage of abstracts that reported non-FDA-approved use. RESULTS: Of the 1549 published abstracts, 271 (17%) disclosed at least one author with financial ties to a company whose products or services were reported. The most common disclosures were for authors who were employees (39%), corporate grant recipients (34%), corporate consultants (23%), or shareholders (18%) of the corporation whose product was studied. A total of 87 (32%) of 271 abstracts with disclosed corporate relationships discussed non-FDA-approved use of a commercial product compared with 197 (15%) of 1278 abstracts with no disclosed tie to industry (P<.001). CONCLUSION: RSNA abstracts in which authors disclosed corporate financial relationships were twice as likely as those without such disclosures to discuss non-FDA-approved use of a commercial product. This raises the possibility that corporate relationships may influence radiology research.
Authors:
Stephen D Brown; Jennifer C Daly; Leslie A Kalish; Samuel A McDaniel
Related Documents :
14551653 - Fda regulation of technology and surgical devices in the operating room.
11185183 - Us manufacturing guideline for ivd products.
11684533 - Comparison of total energy expenditure and energy intake in children aged 6-9 y.
Publication Detail:
Type:  Comparative Study; Journal Article     Date:  2006-04-26
Journal Detail:
Title:  Radiology     Volume:  239     ISSN:  0033-8419     ISO Abbreviation:  Radiology     Publication Date:  2006 Jun 
Date Detail:
Created Date:  2006-05-22     Completed Date:  2006-06-08     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0401260     Medline TA:  Radiology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  849-55     Citation Subset:  AIM; IM    
Copyright Information:
Copyright (c) RSNA, 2006.
Affiliation:
Department of Radiology and Clinical Research Program, Children's Hospital, 300 Longwood Ave, Boston, MA 02115, USA. Stephen.brown@childrens.harvard.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Conflict of Interest*
Congresses as Topic
Consultants
Disclosure*
Employment
Equipment and Supplies
Financial Support* / ethics
Humans
Industry*
Organizational Affiliation
Radiology
Research*
Research Personnel
Research Support as Topic
Retrospective Studies
United States
United States Food and Drug Administration
Comments/Corrections
Comment In:
Radiology. 2006 Jun;239(3):626-8   [PMID:  16714453 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Peripheral arteries: treatment with antibodies of platelet receptors and reteplase for thrombolysis-...
Next Document:  Lesion detection and characterization in a breast US phantom: results of the ACRIN 6666 Investigator...